These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 20096736)

  • 1. Neuroprotective effects of mexiletine on motor evoked potentials in demyelinated rat spinal cords.
    Lee KH; Yoon DH; Chung MA; Sohn JH; Lee HJ; Lee BH
    Neurosci Res; 2010 May; 67(1):59-64. PubMed ID: 20096736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination.
    Jeffery ND; Blakemore WF
    Brain; 1997 Jan; 120 ( Pt 1)():27-37. PubMed ID: 9055795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use-dependent sodium channel blocker mexiletine is neuroprotective against global ischemic injury.
    Hewitt KE; Stys PK; Lesiuk HJ
    Brain Res; 2001 Apr; 898(2):281-7. PubMed ID: 11306014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effect of mexiletine and methylprednisolone on neural function and histopathological damage after transient spinal cord ischemia in rabbits.
    Kazanci A; Seckin H; Karadeniz U; Kazanci D; Turan S; Kazanci B; Yigitkanli K; Bavbek M
    Turk Neurosurg; 2010 Jan; 20(1):43-9. PubMed ID: 20066621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An experimental electro-acupuncture study in treatment of the rat demyelinated spinal cord injury induced by ethidium bromide.
    Huang SF; Ding Y; Ruan JW; Zhang W; Wu JL; He B; Zhang YJ; Li Y; Zeng YS
    Neurosci Res; 2011 Jul; 70(3):294-304. PubMed ID: 21470565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of dorsal column demyelination on evoked potentials in nucleus gracilis.
    Yezierski RP; Devon RM; Vicedomini JP; Broton JG
    J Neurotrauma; 1992; 9(3):231-44. PubMed ID: 1474610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The preventive effect of mexiletine on cerebral ischemic injury following experimental middle cerebral artery occlusion.
    Yilmaz C; Ozger O; Kabatas S; Cansever T; Akar A; Gulsen S; Altinors N; Caner H
    Turk Neurosurg; 2009 Oct; 19(4):367-73. PubMed ID: 19847757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of sodium channel blocker (mexiletine) on pathological ectopic firing pattern in a rat chronic constriction nerve injury model.
    Nakamura S; Atsuta Y
    J Orthop Sci; 2005 May; 10(3):315-20. PubMed ID: 15928896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to anoxic injury in the dorsal columns of adult rat spinal cord following demyelination.
    Imaizumi T; Kocsis JD; Waxman SG
    Brain Res; 1998 Jan; 779(1-2):292-6. PubMed ID: 9473700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The sodium channel blocker RS100642 reverses down-regulation of the sodium channel alpha-subunit Na(v) 1.1 expression caused by transient ischemic brain injury in rats.
    Yao C; Williams AJ; Lu XC; Price RA; Cunningham BS; Berti R; Tortella FC; Dave JR
    Neurotox Res; 2003; 5(4):245-53. PubMed ID: 12835116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delayed granulocyte colony-stimulating factor treatment promotes functional recovery in rats with severe contusive spinal cord injury.
    Lee JS; Yang CC; Kuo YM; Sze CI; Hsu JY; Huang YH; Tzeng SF; Tsai CL; Chen HH; Jou IM
    Spine (Phila Pa 1976); 2012 Jan; 37(1):10-7. PubMed ID: 22024901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective role of quercetin in locomotor activities and cholinergic neurotransmission in rats experimentally demyelinated with ethidium bromide.
    Beckmann DV; Carvalho FB; Mazzanti CM; Dos Santos RP; Andrades AO; Aiello G; Rippilinger A; Graça DL; Abdalla FH; Oliveira LS; Gutierres JM; Schetinger MR; Mazzanti A
    Life Sci; 2014 May; 103(2):79-87. PubMed ID: 24727240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A neuroprotective role of glial cell line-derived neurotrophic factor following moderate spinal cord contusion injury.
    Iannotti C; Ping Zhang Y; Shields CB; Han Y; Burke DA; Xu XM
    Exp Neurol; 2004 Oct; 189(2):317-32. PubMed ID: 15380482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sodium channel blockade with phenytoin protects spinal cord axons, enhances axonal conduction, and improves functional motor recovery after contusion SCI.
    Hains BC; Saab CY; Lo AC; Waxman SG
    Exp Neurol; 2004 Aug; 188(2):365-77. PubMed ID: 15246836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of experimental demyelination on conduction in the central nervous system.
    McDonald WI; Sears TA
    Brain; 1970; 93(3):583-98. PubMed ID: 4319185
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative neuroprotective effect of sodium channel blockers after experimental spinal cord injury.
    Ates O; Cayli SR; Gurses I; Turkoz Y; Tarim O; Cakir CO; Kocak A
    J Clin Neurosci; 2007 Jul; 14(7):658-65. PubMed ID: 17532502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effect of mexiletine in the central nervous system of diabetic rats.
    Ates O; Cayli SR; Altinoz E; Yucel N; Kocak A; Tarim O; Durak A; Turkoz Y; Yologlu S
    Mol Cell Biochem; 2006 Jun; 286(1-2):125-31. PubMed ID: 16541198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ethidium bromide induced demyelination in the spinal cord of the cat.
    Blakemore WF
    Neuropathol Appl Neurobiol; 1982; 8(5):365-75. PubMed ID: 7177337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Characteristic improvement of the function following Schwann cell transplantation for demyelinated spinal cord].
    Imaizumi T; Lankford KL; Kocsis JD; Honmou O; Kohama I; Hashi K
    No Shinkei Geka; 2000 Aug; 28(8):705-11. PubMed ID: 11002493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unexpected mexiletine responses of a mutant cardiac Na+ channel implicate the selectivity filter as a structural determinant of antiarrhythmic drug access.
    Sasaki K; Makita N; Sunami A; Sakurada H; Shirai N; Yokoi H; Kimura A; Tohse N; Hiraoka M; Kitabatake A
    Mol Pharmacol; 2004 Aug; 66(2):330-6. PubMed ID: 15266024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.